Patent US4638802A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4256751A Expired / Lapsed US ⏱️ 0.0 years remaining

Tetrahydroisoquinoline derivatives

Assignee: Tanabe Pharma Corp
•
Filing: 1979-11-08
•
Granted: 1981-03-17
•
Expires: 1999-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula: <IMAGE> (I) wherein R1 is hydrogen or methyl, is prepared by condensing a compound of the formula: <IMAGE> (II) wherein R2 is alkyl, aryl or aralkyl and R1 is same as above, or a reactive derivative thereof with 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid or an ester thereof to give a compound of the formula: <IMAGE> (IV) wherein R3 is an ester residue and R1 and R2 are same as above, followed by hydrolysis or ammonolysis of said compound (IV). The compound (I) is useful as a diagnostic or therapeutic agent for angiotensin-related hypertension.

Inventors

  • 👤 Kimiaki Hayashi
  • 👤 Jyoji Kato
  • 👤 Tomofumi Uchida
  • 👤 Naoto Yoneda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:34
CPC Classifications
C; C07; C07D; C07D217/00; C07D217/22; C07D217/26; A; A61; A61P; A61P43/00; A61P7/00; A61P7/02; A61P9/00; A61P9/12

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 19 words
A compound of the formula: ##STR9## wherein R 1 is hydrogen or methyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 19 words
A compound of the formula: ##STR9## wherein R 1 is hydrogen or methyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 11 words
The compound of claim 1, in which R 1 is methyl.
Claim 4
Dependent Claim 15 words
The compound of claim 1, which is (3S)-2-[(2S)-3-mercapto-2-methylpropionyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 54 words
A hypotensive composition which comprises an amount of a compound of the formula: ##STR10## wherein R 1 is hydrogen or methyl, or a pharmaceutically acceptable salt thereof, and which amount is sufficient, when administered to a warm blooded animal, to provide an effective amount thereof in said animal, and a pharmaceutically acceptable carrier therefor.
Claim 6
Dependent Claim 54 words
A hypotensive composition which comprises an amount of a compound of the formula: ##STR10## wherein R 1 is hydrogen or methyl, or a pharmaceutically acceptable salt thereof, and which amount is sufficient, when administered to a warm blooded animal, to provide an effective amount thereof in said animal, and a pharmaceutically acceptable carrier therefor.

References Cited (Backward Citations)

CA633216A Cited
US4046889A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-16 1984-09-15 1985-03-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-16 1988-09-15 1989-03-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-16 1992-09-15 1993-03-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag